2024 HLS Conference

Join us for a groundbreaking event where artificial intelligence meets healthcare innovation, inclusivity, and diversity. This comprehensive exploration will dive deep into the transformative power of AI in research and healthcare, with a spotlight on creating more inclusive and equitable health solutions. Interested in sponsoring this event? Click here for more information.

Why You Should Attend:

• Emphasis on Diversity and Inclusivity in AI-driven Healthcare:  Engage in thought-provoking conversations about the imperative of fostering inclusivity in healthcare research and delivery. ARPA-H's involvement in this regard, as well as discussions on intentional inclusivity and diversity in AI-driven initiatives, underscored the importance of addressing these aspects for the betterment of drug development, research, and healthcare. Discover how diversity is not just a goal but a means to achieving more effective and universally beneficial healthcare outcomes.
• Microsoft's Role in AI Adoption and Data Management: Gain exclusive insights into how Microsoft is leading the charge in AI adoption, data management, and analysis within the healthcare sector. Learn firsthand about the latest technologies poised to revolutionize drug development, research, and patient care.
• Community Engagement & Concerns in Clinical Research: This event is more than a conference—it's a collaborative platform. Voice your concerns during the Community Town Hall, express your needs related to clinical research, and access to care. Engage with leaders from biotech, pharmaceutical organizations, and Microsoft, all committed to leveraging technology for community benefit.
• Strategic Impact: The discussions will focus on how ARPA-H Spokes, biotech, and pharmaceutical organizations can use Microsoft technologies to address community needs and concerns. The emphasis on data-backed evidence and reporting indicates a strategic approach to addressing challenges in healthcare with the help of advanced technologies, fostering a future where innovation and inclusivity go hand in hand.

Register now and prepare to be part of a movement towards a more inclusive, innovative, and integrated approach to healthcare. 

Additional Event Information

• Online registration deadline: 03 April 2024
• This event is nonrefundable
• Onsite (walk-in) registration is: NOT ALLOWED

ABOUT OUR SPEAKERS

Wade Shen is the director of the Proactive Health Office at ARPA-H where he manages a portfolio of R&D programs that aim to dramatically increase the health span of Americans by increasing their capacity to avoid disease and the symptoms of disease for as long as possible. Wade comes to ARPA-H with extensive experience in academic R&D, startups and in public service. In government, he served as Director of the National AI Initiative Office (NAIIO) at the White House in the Office of Science and Technology Policy (OSTP) and as program manager at DARPA where he ran a portfolio of AI/data science and hardware for AI programs.  Wade was cofounder of Actuate, a nonprofit organization dedicated to bringing the ARPA model of innovation to societal applications outside of national security.  Wade was also a researcher and manager at MIT’s Lincoln Laboratory, where he worked on and oversaw research in AI and natural language understanding.  Wade was co-founder and CTO of Vocentric Corporation, an embedded speech and speaker recognition startup.

Dr. Claude Louis-Charles, MBA, CISSP ("Dr. Claude") is an eminent leader in the technology realm, boasting an impressive tenure of over 30 years in Healthcare IT. His career is distinguished by a steadfast commitment to innovation, excellence in team leadership, and an unparalleled ability to foster partnerships. With a career that spans both the provider/payer and vendor domains, Dr. Claude offers a rare and insightful perspective into the healthcare industry. His decade-long service at Microsoft, coupled with an extensive tenure on the provider/payer side, has equipped him with a comprehensive understanding of the challenges and opportunities within healthcare IT. His contributions have been pivotal in deploying complex, large-scale projects for prominent health institutions, including the HHS, CMS, and CDC. 

Kathleen M. Otto, CEO of BioNorth Texas, a not-for-profit industry trade organization, affiliated with the Biotechnology Innovation Association, www.BIO.org, based in Washington D.C., most recently served as the Executive Director of BioBAT, Inc., the New York City Science and Technology Center at the Brooklyn Army Terminal.  BioBAT’s mission is to refurbish the historic Brooklyn Army Terminal on the NY harbor into sophisticated laboratories offering BsL2, ISO 7/8 manufacturing space, and office space serving the local, national, and international commercial Biotech industry. 

Lauren Adegoke, MS, Biomedical Engineering currently serves as the Chief of Staff at Black Women in Science and Engineering (BWISE) as a fellow. She previously worked at AbbVie as a process development scientist in one of their Co-op programs. There she spearheaded validation studies and worked on one of AbbVie’s new popular drugs, Skyrizi. Lauren previously worked for a local nonprofit as a Program Manager teaching grade school students about STEM. She also mentored high school and college students under the nonprofit. She hopes to inspire other young black women to be bold and take a chance in the hopes of “leveling-up” in their STEM careers. Lauren received her bachelors in Biomedical Engineering (Biomed) with a concentration in Biological Sciences and Neuroscience at the University of North Texas (UNT). She continued her education at UNT and received her Master’s in Biomed in December 2022.

Alexine Tranquada is passionate about improving patients’ lives and addressing health disparities.  She is an award winning pharmaceutical top talent with 25 years in and serving big pharma.  She has led teams at Schering-Plough and Merck in important global commercial functions including -market research, marketing, market access and business development- across the spectrum of therapeutic areas, including immunology, anti-infectives, cardiovascular, metabolics.  She evaluated numerous therapeutics for licensing or acquisition and led the market access assessment for the $11B acquisition of Promethius Bio by Merck in 2023.  

Dr. Tania M. Martin-Mercado, MS, MPH ("Dr. Tania"), is a pioneer in clinical research focusing on genomics, precision medicine, and public health, passionately integrating diversity, equity, and inclusion into healthcare. Transitioning from a distinguished 20-year military career, she founded a biomedical research company and a digital health firm, which won an Innovation Award at the International CES in 2015 for a groundbreaking chronic disease management device. Recently, Dr. Tania established the Gwen Lily Research Foundation (GLRF), aiming to enhance the representation of diverse populations in clinical research through culturally sensitive, community-engaged studies, thereby addressing health disparities. Her work, especially in genetic variations in diseases like systemic lupus erythematosus, underscores her commitment to advancing healthcare. With a PhD in Biomedical Informatics, an MS in Technology Management, and an MPH, Dr. Tania balances her professional achievements with active community involvement and a passion for soccer, demonstrating her multifaceted impact on science and public health.

PRICING

Early Bird Registration: $35.00 Ends March 14, 2024! Act now!

Regular Registration: $45.00

Link to CORPORATE SPONSORSHIP OPPORTUNITIES.

Acknowledgment: By registering for this event, I fully understand that my participation in the program is purely voluntary. I desire to participate and agree to act reasonably and prudently under the circumstances. I further understand that any Gwen Lily Research Foundation (GLRF) volunteers participating in the activity will act individually and will not represent GLRF. As a condition to my participation the activity, I waive and release GLRF and their officers, employees, and agents from any claim that I may have for any damage to property or injury to my person that may result in whole or in part from my participation.

Event Policies

Photography Policy

By registering for this event, you acknowledge that you may be photographed, videotaped, and/or audio-taped during the event and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion, and/or trade and communications media by Gwen Lily Research Foundation (GLRF) in any and all media throughout the world, without restriction as to frequency or duration of usage.

COVID-19 Policy

Gwen Lily Research Foundation requires that all persons who participate in in-person events do so at their own risk and that each participant agrees to the following agreement before taking part in the activity and urges all participants to act in such a manner as to protect their own safety and the safety of others.

Accessibility and Accommodations Policy

Gwen Lily Research Foundation is dedicated to fostering an inclusive environment where everyone's participation is valued. We are committed to making thoughtful adjustments to our policies and programs, aiming to eliminate barriers and provide necessary accommodations. Our goal is to ensure equitable access to all our programming, resources, facilities, and opportunities, allowing everyone to fully engage with and benefit from our programs. Should you need specific accommodation to enhance your experience at this event, please don't hesitate to get in touch with us.